TCL Archive Randomized Trial Finds Supplement Use Didn’t Prevent Prostate Cancer After 5 Years. October 31, 2008
TCL Archive FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug July 26, 2013